Below is the 2021 schedule and agenda for the BIO CEO & Investor Conference.

BIO CEO & Investor Digital Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Digital Conference
Jump to Day
4 Results
Available On-Demand
BALTYMAS is seeking seed funding to commercialize CRT eyedrops - novel drug candidate for treating…
Formosa Pharmaceuticals is a Taiwan-based biotechnology firm with international alliances in US and…
Ocuphire is a clinical-stage ophthalmic biopharmaceutical company focused on developing and…
Ripple Therapeutics is a clinical stage company focused on improving ophthalmic therapeutics with…